These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1878425)

  • 1. Immune hemolytic anemia and renal failure associated with rifampicin-dependent antibodies with anti-I specificity.
    Pereira A; Sanz C; Cervantes F; Castillo R
    Ann Hematol; 1991 Jul; 63(1):56-8. PubMed ID: 1878425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red cell I antigen as immune complex receptor in drug-induced hemolytic anemias.
    Duran-Suarez JR; Martin-Vega C; Argelagues E; Massuet L; Ribera A; Triginer J
    Vox Sang; 1981; 41(5-6):313-5. PubMed ID: 7324446
    [No Abstract]   [Full Text] [Related]  

  • 3. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.
    De Vriese AS; Robbrecht DL; Vanholder RC; Vogelaers DP; Lameire NH
    Am J Kidney Dis; 1998 Jan; 31(1):108-15. PubMed ID: 9428460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin-dependent reactions against erythrocytes in the sera of patients receiving rifampicin therapy.
    Schubothe H; Weber S
    Scand J Respir Dis Suppl; 1973; 84():53-9. PubMed ID: 4544602
    [No Abstract]   [Full Text] [Related]  

  • 5. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis.
    Garratty G; Postoway N; Schwellenbach J; McMahill PC
    Transfusion; 1991 Feb; 31(2):176-9. PubMed ID: 1825363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrent hemolytic accidents of immuno-allergic origin during intermittent treatment with rifampicin].
    Sors C; Sarrazin A; Homberg JC
    Rev Tuberc Pneumol (Paris); 1972; 36(3):405-16. PubMed ID: 5080967
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute hemolysis and renal failure with rifampicin-dependent antibodies after discontinuous administration.
    Tahan SR; Diamond JR; Blank JM; Horan RF
    Transfusion; 1985; 25(2):124-7. PubMed ID: 3984005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular haemolysis and renal failure caused by intermittent rifampicin treatment.
    Criel A; Verwilghen RL
    Blut; 1980 Feb; 40(2):147-50. PubMed ID: 7353082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure caused by rifampicin re-exposure with 10-year of interval.
    Tsai TL; Lee CH; Chuang FR; Hsu KT
    Chang Gung Med J; 2001 Nov; 24(11):729-33. PubMed ID: 11820654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemolytic anemia associated with multiple autoantibodies and low serum complement.
    Moake JL; Schultz DR
    Am J Med; 1975 Mar; 58(3):431-7. PubMed ID: 1078754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular hemolytic anemia in a patient with antibodies related to meropenem.
    Oka S; Shiragami H; Nohgawa M
    Intern Med; 2015; 54(10):1291-5. PubMed ID: 25986273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2 cases of hemolytic complications during intermittent treatment with rifampicin].
    Năstase M; Brener E; Năstase R; Borgovan L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):43-6. PubMed ID: 171722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Belated diagnosis in three patients with rifampicin-induced immune haemolytic anaemia.
    Ahrens N; Genth R; Salama A
    Br J Haematol; 2002 May; 117(2):441-3. PubMed ID: 11972531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Haemolytic crisis with acute renal failure during rifampicin treatment (author's transl)].
    Möhring K; Asbach HW; Schubothe H; Weber S
    Dtsch Med Wochenschr; 1974 Jul; 99(27):1458-62. PubMed ID: 4843504
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immune hemolytic anemia and acute kidney failure due to rifampicin].
    Guzzini F; Angiolini F; Cazzaniga L; Gasparini P; Milvio E; Mosconi L
    Recenti Prog Med; 1994 Mar; 85(3):182-5. PubMed ID: 8184201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rifampicin-induced immune hemolytic anemia: therapeutic relevance of plasma exchange.
    Govoni M; Moretti M; Menini C; Fiocchi F
    Vox Sang; 1990; 59(4):246-7. PubMed ID: 2293464
    [No Abstract]   [Full Text] [Related]  

  • 17. 'Immune complex' mediated intravascular hemolysis due to IgM cephalosporin-dependent antibody.
    Salama A; Göttsche B; Schleiffer T; Mueller-Eckhardt C
    Transfusion; 1987; 27(6):460-3. PubMed ID: 3500531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemolytic crisis and acute kidney failure from rifampicin].
    Conen D; Blumberg A; Weber S; Schubothe H
    Schweiz Med Wochenschr; 1979 Apr; 109(15):558-62. PubMed ID: 441713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin-induced immune thrombocytopenia.
    Blajchman MA; Lowry RC; Pettit JE; Stradling P
    Br Med J; 1970 Jul; 3(5713):24-6. PubMed ID: 5427483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemolytic anemia caused by irregular rifampicin therapy.
    Oğuz A; Kanra T; Gökalp A; Gültekin A
    Turk J Pediatr; 1989; 31(1):83-8. PubMed ID: 2609438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.